Biognosys’ Spectronaut® Now Available Through Thermo Fisher Scientific
ZURICH and NEWTON, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE)
Biognosys, a pioneer in software solutions for mass spectrometry-based proteomics data analysis, has announced a groundbreaking partnership with Thermo Fisher Scientific. This collaboration brings Biognosys’ Spectronaut® software directly to end users through Thermo Fisher’s extensive product catalog. This reselling agreement marks a significant milestone in the field of proteomics, providing researchers with unparalleled access to cutting-edge technology.
Streamlined Access to State-of-the-Art Mass Spectrometry Systems
Under this new agreement, researchers can now acquire Thermo Scientific mass spectrometry systems along with Biognosys’ Spectronaut® software through a single offer from Thermo Fisher. This integrated approach simplifies the purchasing process and ensures that users have everything they need to conduct advanced proteomics research at their fingertips.
Biognosys’ Spectronaut® software is known for its vendor-agnostic capabilities, making it compatible with a wide range of mass spectrometry systems. By partnering with Thermo Fisher, Biognosys is expanding access to its innovative software and empowering researchers to achieve new insights in their proteomics studies.
Implications for Researchers and the Scientific Community
This collaboration between Biognosys and Thermo Fisher has the potential to revolutionize the field of proteomics. By offering a seamless purchasing experience and combining state-of-the-art hardware with advanced software, researchers will be able to accelerate their discovery process and uncover new findings in the realm of protein analysis.
With Biognosys’ Spectronaut® now directly available through Thermo Fisher, scientists can expect a more streamlined and efficient workflow for their proteomics experiments. This partnership represents a significant step forward in the quest to unravel the complexities of the human proteome and drive innovation in the scientific community.
Effects on Individuals:
For individuals, this partnership means greater access to cutting-edge technology for proteomics research. Researchers can now easily acquire Biognosys’ Spectronaut® software along with Thermo Scientific mass spectrometry systems, streamlining their workflow and enabling them to make new discoveries in the field of protein analysis.
Effects on the World:
On a global scale, the collaboration between Biognosys and Thermo Fisher has the potential to advance our understanding of the human proteome and contribute to breakthroughs in medical research. By providing researchers with integrated access to state-of-the-art mass spectrometry systems and innovative software, this partnership could pave the way for new treatments and diagnostic tools in the fight against complex diseases.
Conclusion:
The reselling agreement between Biognosys and Thermo Fisher represents a significant advancement in the field of proteomics research. By offering seamless access to Spectronaut® software and Thermo Scientific mass spectrometry systems, this collaboration has the potential to drive innovation, accelerate discovery, and ultimately impact the way we understand and treat disease. Researchers and the scientific community as a whole stand to benefit greatly from this partnership, opening up new possibilities for groundbreaking research and transformative advancements in the field of proteomics.
